col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


239 Results       Page 1

 [1] 
Elsevier: Cell Reports
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―17 Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants Pei Li, Julia N. Faraone, Cheng Chih Hsu, Michelle Chamblee, Yi-Min Zheng, Claire Carlin, et al. (+10)
2 [GO] 2024―Jul―05 Combining genomic data and infection estimates to characterize the complex dynamics of SARS-CoV-2 Omicron variants in the US Rafael Lopes, Kien Pham, Fayette Klaassen, Melanie H. Chitwood, Anne M. Hahn, Seth Redmond, et al. (+5)
3 [GO] 2024―Jun―18 Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection Xiao-Lin Jiang, Xue-Dong Song, Chao Shi, Guo-Jian Yang, Xue-Jun Wang, Yu-Wei Zhang, et al. (+12)
4 [GO] 2024―Jun―12 Single-cell-resolved interspecies comparison shows a shared inflammatory axis and a dominant neutrophil-endothelial program in severe COVID-19 Stefan Peidli, Geraldine Nouailles, Emanuel Wyler, Julia M. Adler, Sandra Kunder, Anne Voß, et al. (+12)
5 [GO] 2024―Jun―12 Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1 Zhou Tong, Jianyu Tong, Wenwen Lei, Yufeng Xie, Yingzi Cui, Guowen Jia, et al. (+17)
6 [GO] 2024―Jun―05 Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes Jonathan Hurtado, Thomas F. Rogers, David B. Jaffe, Bruce A. Adams, Sandhya Bangaru, Elijah Garcia, et al. (+16)
7 [GO] 2024―May―27 An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike Banghui Liu, Xuefeng Niu, Yijun Deng, Zhaoyong Zhang, Yanqun Wang, Xijie Gao, et al. (+18)
8 [GO] 2024―Apr―10 SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epithelia Rita M. Meganck, Caitlin E. Edwards, Michael L. Mallory, Rhianna E. Lee, Hong Dang, Alexis B. Bailey, et al. (+19)
9 [GO] 2024―Mar―15 Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity Zemin Yang, Bryan A. Johnson, Victoria A. Meliopoulos, Xiaohui Ju, Peipei Zhang, Michael P. Hughes, et al. (+22)
10 [GO] 2024―Mar―07 CD8+ T cell memory induced by successive SARS-CoV-2 mRNA vaccinations is characterized by shifts in clonal dominance Hiroyasu Aoki, Masahiro Kitabatake, Haruka Abe, Peng Xu, Mikiya Tsunoda, Shigeyuki Shichino, et al. (+6)
11 [GO] 2024―Feb―29 SARS-CoV-2 targets ribosomal RNA biogenesis V. Talya Yerlici, Audrey Astori, Nevraj S. Kejiou, Chris A. Jordan, Negin Khosraviani, Janet N.Y. Chan, et al. (+4)
12 [GO] 2024―Jan―30 Two-step evolution of HIV-1 budding system leading to pandemic in the human population Yoriyuki Konno, Keiya Uriu, Takayuki Chikata, Toru Takada, Jun-ichi Kurita, Mahoko Takahashi Ueda, et al. (+14)
13 [GO] 2024―Jan―21 Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury Yiheng Mao, Ying Chen, Yuan Li, Longda Ma, Xi Wang, Qi Wang, et al. (+13)
14 [GO] 2024―Jan―08 Ipsilateral immunization after a prior SARS-CoV-2 mRNA vaccination elicits superior B cell responses compared to contralateral immunization Wenxia Jiang, Alexander R. Maldeney, Xue Yuan, Martin J. Richer, Scott E. Renshaw, Wei Luo
15 [GO] 2023―Dec―20 The HLA-II immunopeptidome of SARS-CoV-2 Shira Weingarten-Gabbay, Da-Yuan Chen, Siranush Sarkizova, Hannah B. Taylor, Matteo Gentili, Gabrielle M. Hernandez, et al. (+9)
16 [GO] 2023―Dec―15 Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo Ryuta Uraki, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Seiya Yamayoshi, Mutsumi Ito, Shiho Chiba, et al. (+14)
17 [GO] 2023―Nov―21 Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53 Jonathan D. Lee, Bridget L. Menasche, Maria Mavrikaki, Madison M. Uyemura, Su Min Hong, Nina Kozlova, et al. (+12)
18 [GO] 2023―Nov―18 Evolution of the SARS-CoV-2 Omicron spike Ruth J. Parsons, Priyamvada Acharya
19 [GO] 2023―Oct―28 Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines Yixiang Deng, Caroline Atyeo, Dansu Yuan, Taras M. Chicz, Timothy Tibbitts, Matthew Gorman, et al. (+6)
20 [GO] 2023―Oct―23 Transgenic mouse models support a protective role of type I IFN response in SARS-CoV-2 infection-related lung immunopathology and neuroinvasion Nishant Ranjan Chauhan, Soumya Kundu, Ramyasingh Bal, Diya Chattopadhyay, Rinku Sahu, Subhash Mehto, et al. (+14)
21 [GO] 2023―Oct―04 Organ-specific immunity: A tissue analysis framework for investigating local immune responses to SARS-CoV-2 Alphonsus H.C. Ng, Huiqian Hu, Kai Wang, Kelsey Scherler, Sarah E. Warren, Daniel R. Zollinger, et al. (+15)
22 [GO] 2023―Sep―19 Structural basis for translation inhibition by MERS-CoV Nsp1 reveals a conserved mechanism for betacoronaviruses Swapnil C. Devarkar, Michael Vetick, Shravani Balaji, Ivan B. Lomakin, Luojia Yang, Danni Jin, et al. (+3)
23 [GO] 2023―Sep―13 Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron Anamika Patel, Sanjeev Kumar, Lilin Lai, Meredith Keen, Rajesh Valanparambil, Chennareddy Chakravarthy, et al. (+14)
24 [GO] 2023―Sep―06 SARS-CoV-2 variants with NSP12 P323L/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility Se-Mi Kim, Eun-Ha Kim, Mark Anthony B. Casel, Young-Il Kim, Rong Sun, Mi-Jeong Kwak, et al. (+15)
25 [GO] 2023―Aug―16 Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly Isabella A.T.M. Ferreira, Colin Y.C. Lee, William S. Foster, Adam Abdullahi, Lisa M. Dratva, Zewen Kelvin Tuong, et al. (+26)
26 [GO] 2023―Aug―14 Genome-wide CRISPR screens identify noncanonical translation factor eIF2A as an enhancer of SARS-CoV-2 programmed -1 ribosomal frameshifting Lian-Huan Wei, Yu Sun, Junjie U. Guo
27 [GO] 2023―Jul―21 A comprehensive Drosophila resource to identify key functional interactions between SARS-CoV-2 factors and host proteins Annabel Guichard, Shenzhao Lu, Oguz Kanca, Daniel Bressan, Yan Huang, Mengqi Ma, et al. (+21)
28 [GO] 2023―Jul―20 Super-resolution proximity labeling reveals anti-viral protein network and its structural changes against SARS-CoV-2 viral proteins Yun-Bin Lee, Minkyo Jung, Jeesoo Kim, Afandi Charles, Wanda Christ, Jiwoong Kang, et al. (+7)
29 [GO] 2023―Jul―19 Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity Yuan Chen, Georgina H. Mason, D. Oliver Scourfield, Alexander Greenshields-Watson, Tracey A. Haigh, Andrew K. Sewell, et al. (+5)
30 [GO] 2023―Jul―12 Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine Felipe Lopes de Assis, Kenneth B. Hoehn, Xiaozhen Zhang, Lela Kardava, Connor D. Smith, Omar El Merhebi, et al. (+14)
31 [GO] 2023―May―30 Extrafollicular IgD-CD27-CXCR5-CD11c- DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19 Hugues Allard-Chamard, Naoki Kaneko, Alice Bertocchi, Na Sun, Julie Boucau, Hsiao-Hsuan Kuo, et al. (+19)
32 [GO] 2023―May―29 Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity Martin Potts, Alice Fletcher-Etherington, Katie Nightingale, Federica Mescia, Laura Bergamaschi, Fernando J. Calero-Nieto, et al. (+13)
33 [GO] 2023―May―26 Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail Amin Addetia, Young-Jun Park, Tyler Starr, Allison J. Greaney, Kaitlin R. Sprouse, John E. Bowen, et al. (+6)
34 [GO] 2023―May―03 Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron Variants Jianbo Wu, Zhenguo Chen, Yidan Gao, Zegen Wang, Jiarong Wang, Bing-Yu Chiang, et al. (+16)
35 [GO] 2023―Apr―21 Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination Zixi Yin, Ji-Li Chen, Yongxu Lu, Beibei Wang, Leila Godfrey, Alexander J. Mentzer, et al. (+26)
36 [GO] 2023―Apr―04 Vaccination provides superior in vivo recall capacity of SARS-CoV-2 specific memory CD8 T cells Inga Kavazović, Christoforos Dimitropoulos, Dora Gašparini, Mari Rončević Filipović, Igor Barković, Jan Koster, et al. (+4)
37 [GO] 2023―Apr―03 Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses Audrey Kassardjian, Eric Sun, Jamie Sookhoo, Krithika Muthuraman, Kayluz Frias Boligan, Iga Kucharska, et al. (+6)
38 [GO] 2023―Mar―15 The changing health impact of vaccines in the COVID-19 pandemic: a modeling study Jamie A. Cohen, Robyn M. Stuart, Jasmina Panovska-Griffiths, Edinah Mudimu, Romesh G. Abeysuriya, Cliff C. Kerr, et al. (+2)
39 [GO] 2023―Mar―15 The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2 Joel D. Allen, Dylan Ivory, Sophie Ge Song, Wan-ting He, Tazio Capozzola, Peter Yong, et al. (+3)
40 [GO] 2023―Mar―10 Coronavirus Subverts ER-phagy by Hijacking FAM134B and ATL3 into p62 Condensates to Facilitate Viral Replication Xuan Tan, Kun Cai, Jiajia Li, Zhen Yuan, Ruifeng Chen, Hurong Xiao, et al. (+4)
41 [GO] 2023―Mar―09 Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infection Nicolas Fossat, Emma A. Lundsgaard, Rui Costa, Lizandro R. Rivera-Rangel, Louise Nielsen, Lotte S. Mikkelsen, et al. (+3)
42 [GO] 2023―Mar―07 Rapid escape of new SARS-CoV-2 Omicron variants from BA.2 directed antibody responses. Aiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, Helen M. Ginn, Chang Liu, Helen M.E. Duyvesteyn, et al. (+25)
43 [GO] 2023―Mar―06 Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain Leerang Yang, Matthew Van Beek, Zijun Wang, Frauke Muecksch, Marie Canis, Theodora Hatziioannou, et al. (+3)
44 [GO] 2023―Mar―06 Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines Thayne H. Dickey, Rui Ma, Sachy Orr-Gonzalez, Tarik Ouahes, Palak Patel, Holly McAleese, et al. (+9)
45 [GO] 2023―Feb―17 SARS-CoV-2 spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID syndrome in mice Fabricia L. Fontes-Dantas, Gabriel G. Fernandes, Elisa G. Gutman, Emanuelle V. De Lima, Leticia S. Antonio, Mariana B. Hammerle, et al. (+19)
46 [GO] 2023―Jan―30 CRISPR screening reveals a requirement for ribosome recycling in efficient SARS-CoV-2 programmed ribosomal frameshifting and viral replication Frederick Rehfeld, Jennifer L. Eitson, Maikke B. Ohlson, Tsung-Cheng Chang, John W. Schoggins, Joshua T. Mendell
47 [GO] 2023―Jan―17 Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2 Julia Z. Adamska, Rohit Verma, Shakti Gupta, Thomas Hagan, Florian Wimmers, Katherine Floyd, et al. (+10)
48 [GO] 2023―Jan―09 SARS-CoV-2 Omicron subvariants Spike recognition and neutralization elicited after the third dose of mRNA vaccine Alexandra Tauzin, Alexandre Nicolas, Shilei Ding, Mehdi Benlarbi, Halima Medjahed, Debashree Chatterjee, et al. (+17)
49 [GO] 2023―Jan―09 Prevalent and immunodominant CD8 T-cell epitopes are conserved in SARS-CoV-2 variants Saskia Meyer, Isaac Blaas, Ravi Chand Bollineni, Marina Delic-Sarac, Trung T. Tran, Cathrine Knetter, et al. (+14)
50 [GO] 2022―Dec―26 Liquid-Liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication Bao-An Chau, Venessa Chen, Alan W. Cochrane, Leslie J. Parent, Andrew J. Mouland
51 [GO] 2022―Dec―12 SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D Madeline J. Lee, Michelle W. Leong, Arjun Rustagi, Aimee Beck, Leiping Zeng, Susan Holmes, et al. (+2)
52 [GO] 2022―Nov―29 Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017 Yunfei Jia, Sheng Niu, Yu Hu, Yan Chai, Anqi Zheng, Chao Su, et al. (+12)
53 [GO] 2022―Nov―22 Bulk IgG Glycosylation Predicts COVID-19 Severity and Vaccine Antibody Response Michelle K. Ash, Pavan P. Bhimalli, Byoung-Kyu Cho, Basil Baby Mattamana, Stéphanie Gambut, Imad Tarhoni, et al. (+15)
54 [GO] 2022―Nov―10 Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine Xuping Xie, Jing Zou, Chaitanya Kurhade, Mingru Liu, Ping Ren, Pei-Yong Shi
55 [GO] 2022―Nov―07 Shared genetic influences between blood analyte levels and risk of severe COVID-19 Hamzeh M. Tanha, Anita Sathyanarayanan, Divya Mehta, Dale R. Nyholt
56 [GO] 2022―Oct―27 Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2 Meng Yuan, Yiquan Wang, Huibin Lv, Timothy J.C. Tan, Ian A. Wilson, Nicholas C. Wu
57 [GO] 2022―Oct―18 SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations Elizabeth M. Anderson, Shuk Hang Li, Moses Awofolaju, Theresa Eilola, Eileen Goodwin, Marcus J. Bolton, et al. (+19)
58 [GO] 2022―Oct―12 SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19 Danielle Beckman, Alyssa Bonillas, Giovanne B. Diniz, Sean Ott, Jamin W. Roh, Sonny R. Elizaldi, et al. (+5)
59 [GO] 2022―Oct―05 ZBTB7A promotes virus-host homeostasis during human coronavirus 229E infection Xinyu Zhu, Joseph D. Trimarco, Courtney A. Williams, Alejandro Barrera, Timothy E. Reddy, Nicholas S. Heaton
60 [GO] 2022―Oct―05 A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses Alexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, Shilei Ding, Mark M. Painter, Rishi R. Goel, et al. (+26)
61 [GO] 2022―Oct―05 BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age Timothy A. Bates, Pei Lu, Ye jin Kang, Devin Schoen, Micah Thornton, Savannah K. McBride, et al. (+6)
62 [GO] 2022―Sep―30 Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants Zhaochun Chen, Peng Zhang, Yumiko Matsuoka, Yaroslav Tsybovsky, Kamille West, Celia Santos, et al. (+18)
63 [GO] 2022―Aug―29 Spike Protein-independent Attenuation of SARS-CoV-2 Omicron Variant in Laboratory Mice Shufeng Liu, Prabhuanand Selvaraj, Kotou Sangare, Binquan Luan, Tony T. Wang
64 [GO] 2022―Aug―23 A key F27I substitution within HCDR1 facilitates the rapid maturation of P2C-1F11-like neutralizing antibodies in a SARS-CoV-2-infected donor Miao Wang, Qing Fan, Bing Zhou, Haocheng Ye, Senlin Shen, Jiazhen Yu, et al. (+4)
65 [GO] 2022―Aug―15 N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products Kyusik Q. Kim, Bhagyashri D. Burgute, Shin-Cheng Tzeng, Crystal Jing, Courtney Jungers, Junya Zhang, et al. (+5)
66 [GO] 2022―Aug―15 Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice Alexandra C. Walls, Laura A. VanBlargan, Kai Wu, Angela Choi, Mary Jane Navarro, Diana Lee, et al. (+24)
67 [GO] 2022―Aug―12 SARS-CoV-2 Vaccine-Induced Antibody and T-Cell Response in SARS-CoV-1 Survivors Li-Jun Duan, Xiao-Ming Cui, Ka-Li Zhu, Lin Yao, Guo-Lin Wang, Wu-Chun Cao, Mai-Juan Ma
68 [GO] 2022―Aug―11 A neutralizing epitope on the SD1 domain of SARS-CoV-2 Spike targeted following infection and vaccination. Jeffrey Seow, Hataf Khan, Annachiara Rosa, Valeria Calvaresi, Carl Graham, Suzanne Pickering, et al. (+7)
69 [GO] 2022―Aug―03 SARS-CoV-2 Spike N-Terminal Domain modulates TMPRSS2-dependent viral entry and fusogenicity Bo Meng, Rawlings Datir, Jinwook Choi, John R. Bradley, Kenneth GC. Smith, Joo Hyeon Lee, Ravindra K. Gupta
70 [GO] 2022―Aug―03 Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization Aileen Ebenig, Samada Muraleedharan, Julia Kazmierski, Daniel Todt, Arne Auste, Martina Anzaghe, et al. (+21)
71 [GO] 2022―Jul―19 Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species Lei Peng, Zhenhao Fang, Paul A. Renauer, Andrew McNamara, Jonathan J. Park, Qianqian Lin, et al. (+6)
72 [GO] 2022―Jul―14 Plasmacytoid Dendritic Cells during COVID-19: ally or adversary? Renée Marije van der Sluis, Christian Kanstrup Holm, Martin Roelsgaard Jakobsen
73 [GO] 2022―Jul―04 Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition Ju-Ri Sim, Dong Hoon Shin, Pil-Gu Park, So-Hyeon Park, Joon-Yong Bae, Youngchae Lee, et al. (+24)
74 [GO] 2022―Jun―27 Viral E Protein Neutralizes BET Protein-Mediated Post-Entry Antagonism of SARS-CoV-2 Irene P. Chen, James E. Longbotham, Sarah McMahon, Rahul K. Suryawanshi, Mir M. Khalid, Taha Y. Taha, et al. (+16)
75 [GO] 2022―Jun―21 Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques Huiwen Zheng, Yanli Chen, Jing Li, Heng Li, Xin Zhao, Jiali Li, et al. (+10)
76 [GO] 2022―Jun―14 SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues Matteo D’Antonio, Jennifer P. Nguyen, Timothy D. Arthur, Hiroko Matsui, Agnieszka D’Antonio-Chronowska, Kelly A. Frazer
77 [GO] 2022―Jun―13 Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19 Sai Preetham Peddireddy, Syed A. Rahman, Anthony R. Cillo, Godhev Manakkat Vijay, Ashwin Somasundaram, Creg J. Workman, et al. (+13)
78 [GO] 2022―Jun―13 COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus Spike proteins Evan A. Elko, Georgia A. Nelson, Heather L. Mead, Erin J. Kelley, Sophia T. Carvalho, Nathan G. Sarbo, et al. (+18)
79 [GO] 2022―Jun―09 A diminished immune response underlies age-related SARS-CoV-2 pathologies Kohei Oishi, Shu Horiuchi, Justin Frere, Robert E. Schwartz, Benjamin R. tenOever
80 [GO] 2022―Jun―08 Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike Victoria Stalls, Jared Lindenberger, Sophie M.-C. Gobeil, Rory Henderson, Rob Parks, Maggie Barr, et al. (+17)
81 [GO] 2022―May―30 Emerging viruses: Cross-species transmission of Coronaviruses, Filoviruses, Henipaviruses and Rotaviruses from bats Jin Tian, Jiumeng Sun, Dongyan Li, Ningning Wang, Lifang Wang, Chang Zhang, et al. (+7)
82 [GO] 2022―May―27 Spatial region-resolved proteome map reveals mechanism of COVID-19-associated heart injury Ling Leng, Jie Ma, Pei-Pei Zhang, Si-Chi Xu, Xiao Li, Ye Jin, et al. (+20)
83 [GO] 2022―May―27 Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles Aniuska Becerra-Artiles, J. Mauricio Calvo-Calle, Mary Dawn Co, Padma P. Nanaware, John Cruz, Grant C. Weaver, et al. (+5)
84 [GO] 2022―May―26 Parsing the role of NSP1 in SARS-CoV-2 infection Tal Fisher, Avi Gluck, Krishna Narayanan, Makoto Kuroda, Aharon Nachshon, Jason, et al. (+13)
85 [GO] 2022―May―25 BARICITINIB ATTENUATES THE PROINFLAMMATORY PHASE OF COVID-19 DRIVEN BY LUNG-INFILTRATING MONOCYTES Brian Dobosh, Keivan Zandi, Diego Moncada Giraldo, Shu Ling Goh, Kathryn Musall, Milagros Aldeco, et al. (+9)
86 [GO] 2022―May―25 Single cell RNA sequencing reveals immunological rewiring at the maternal-fetal interface following asymptomatic/mild SARS-CoV-2 infection Suhas Sureshchandra, Michael Z. Zulu, Brianna M. Doratt, Allen Jankeel, Delia Tifrea, Robert Edwards, et al. (+3)
87 [GO] 2022―May―20 Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529 Qian Wang, Saumya Anang, Sho Iketani, Yicheng Guo, Lihong Liu, Phinikoula S. Katsamba, et al. (+3)
88 [GO] 2022―May―16 IgG targeting distinct seasonal coronavirus OC43-conserved SARS-CoV-2 spike subdomains correlate with differential COVID-19 disease outcomes Jose L. Garrido, Matías A. Medina, Felipe Bravo, Sarah McGee, Francisco Fuentes-Villalobos, Mario Calvo, et al. (+6)
89 [GO] 2022―May―16 Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants by Modular, Tetravalent, Bi-paratopic Antibodies Shane Miersch, Nitin Sharma, Reza Saberianfar, Chao Chen, Francesca Caccuri, Alberto Zani, et al. (+6)
90 [GO] 2022―May―08 Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron Siling Wang, Hui Sun, Yali Zhang, Lunzhi Yuan, Yizhen Wang, Tianying Zhang, et al. (+20)
91 [GO] 2022―May―08 Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques Huiwen Zheng, Yanli Chen, Jing Li, Heng Li, Xin Zhao, Jiali Li, et al. (+10)
92 [GO] 2022―Apr―29 Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant Yang Liu, Jianying Liu, Bryan A. Johnson, Hongjie Xia, Zhiqiang Ku, Craig Schindewolf, et al. (+6)
93 [GO] 2022―Apr―26 Characterization and functional interrogation of the SARS-CoV-2 RNA interactome Athéna Labeau, Luc Fery-Simonian, Alain Lefevre-Utile, Marie Pourcelot, Lucie Bonnet-Madin, Vassili Soumelis, et al. (+4)
94 [GO] 2022―Apr―25 LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, et al. (+63)
95 [GO] 2022―Apr―21 Nasally-delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron Zhenlu Chong, Courtney E. Karl, Peter J. Halfmann, Yoshihiro Kawaoka, Emma S. Winkler, Shamus P. Keeler, et al. (+3)
96 [GO] 2022―Apr―19 Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry Enya Qing, Pengfei Li, Laura Cooper, Sebastian Schulz, Hans-Martin Jäck, Lijun Rong, et al. (+2)
97 [GO] 2022―Apr―15 SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination Prerna Arora, Amy Kempf, Inga Nehlmeier, Luise Graichen, Martin S. Winkler, Martin Lier, et al. (+7)
98 [GO] 2022―Apr―15 ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants Jeffrey Seow, Carl Graham, Sadie R. Hallett, Thomas Lechmere, Thomas J.A. Maguire, Isabella Huettner, et al. (+12)
99 [GO] 2022―Apr―11 Structural and functional impact by SARS-CoV-2 Omicron spike mutations Jun Zhang, Yongfei Cai, Christy L. Lavine, Hanqin Peng, Haisun Zhu, Krishna Anand, et al. (+12)
100 [GO] 2022―Apr―09 Dynamic Ca2+ sensitivity stimulates the evolved SARS-CoV-2 spike strain-mediated membrane fusion for enhanced entry Puspangana Singh, Shreya Mukherji, Swarnendu Basak, Markus Hoffmann, Dibyendu Kumar Das
101 [GO] 2022―Apr―04 Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection Devin J. Kenney, Aoife K. O’Connell, Jacquelyn Turcinovic, Paige Montanaro, Ryan M. Hekman, Tomokazu Tamura, et al. (+30)
102 [GO] 2022―Mar―25 mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron Hye Kyung Lee, Ludwig Knabl, Juan I. Moliva, Ludwig Knabl, Anne P. Werner, Seyhan Boyoglu-Barnum, et al. (+6)
103 [GO] 2022―Mar―07 Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants Yali Zhang, Min Wei, Yangtao Wu, Juan Wang, Yuting Hong, Yang Huang, et al. (+26)
104 [GO] 2022―Mar―07 Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting Blake M. Hauser, Maya Sangesland, Kerri J. St. Denis, Evan C. Lam, James Brett Case, Ian W. Windsor, et al. (+7)
105 [GO] 2022―Feb―22 SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract Frederick Hansen, Kimberly Meade-White, Chad Clancy, Rebecca Rosenke, Atsushi Okumura, David W. Hawman, et al. (+5)
106 [GO] 2022―Feb―21 Limited Extent and Consequences of Pancreatic SARS-CoV-2 Infection Verena van der Heide, Sonia Jangra, Phillip Cohen, Raveen Rathnasinghe, Sadaf Aslam, Teresa Aydillo, et al. (+19)
107 [GO] 2022―Feb―21 SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells Quirin Hammer, Josefine Dunst, Wanda Christ, Francesca Picarazzi, Mareike Wendorff, Pouria Momayyezi, et al. (+20)
108 [GO] 2022―Feb―21 BCG vaccination provides protection against IAV but not SARS-CoV-2 Eva Kaufmann, Nargis Khan, Kim A. Tran, Antigona Ulndreaj, Erwan Pernet, Ghislaine Fontes, et al. (+18)
109 [GO] 2022―Feb―08 SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses Debashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, Shang Yu Gong, Marianne Boutin, Catherine Bourassa, et al. (+26)
110 [GO] 2022―Feb―07 Cryo-EM structure of the SARS-CoV-2 omicron spike Gabriele Cerutti, Yicheng Guo, Lihong Liu, Liyuan Liu, Zhening Zhang, Yang Luo, et al. (+5)
111 [GO] 2022―Feb―01 Follicular T Cells Optimize the Germinal Center Response to SARS-CoV-2 Protein Vaccination in Mice Cecilia B. Cavazzoni, Benjamin L. Hanson, Manuel A. Podestà, Elsa D. Bechu, Rachel L. Clement, Hengcheng Zhang, et al. (+8)
112 [GO] 2022―Jan―31 Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model Peter J. Halfmann, Makoto Kuroda, Tammy Armbrust, Molly Accola, Riccardo Valdez, Theresa Kowalski-Dobson, et al. (+3)
113 [GO] 2022―Jan―31 B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination Prasanti Kotagiri, Federica Mescia, William M. Rae, Laura Bergamaschi, Zewen K. Tuong, Lorinda Turner, et al. (+14)
114 [GO] 2022―Jan―28 SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models Bettina Stolp, Marcel Stern, Ina Ambiel, Katharina Hofmann, Katharina Morath, Lara Gallucci, et al. (+7)
115 [GO] 2022―Jan―25 A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection Guillaume Beaudoin-Bussières, Yaozong Chen, Irfan Ullah, Jérémie Prévost, William D. Tolbert, Kelly Symmes, et al. (+20)
116 [GO] 2022―Jan―20 SARS-CoV-2 mRNA Vaccine Induces Robust Specific and Cross-reactive IgG and Unequal Neutralizing Antibodies in Naïve and Previously Infected Recipients Tara M. Narowski, Kristin Raphel, Lily E. Adams, Jenny Huang, Nadja A. Vielot, Ramesh Jadi, et al. (+4)
117 [GO] 2022―Jan―20 Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display Shiho Tanaka, C. Anders Olson, Christopher O. Barnes, Wendy Higashide, Marcos Gonzalez, Justin Taft, et al. (+9)
118 [GO] 2022―Jan―19 Maintenance of broad neutralising antibodies and memory B cells 12 months post-infection is predicted by SARS-CoV-2 specific CD4+ T cell responses Harikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, Anurag Adhikari, Chaturaka Rodrigo, Mohamed Hammoud, et al. (+26)
119 [GO] 2022―Jan―19 Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway. Jie Zhou, Thomas P. Peacock, Jonathan C. Brown, Daniel H. Goldhill, Ahmed M.E. Elrefaey, Rebekah Penrice-Randal, et al. (+23)
120 [GO] 2022―Jan―11 Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drive rapid and potent immunogenicity capable of single-dose protection Kylie M. Konrath, Kevin Liaw, Yuanhan Wu, Xizhou Zhu, Susanne N. Walker, Ziyang Xu, et al. (+23)
121 [GO] 2021―Dec―28 Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19 Xiaojie Bi, Wei Liu, Xuan Ding, Shuang Liang, Yufen Zheng, Xiaoli Zhu, et al. (+26)
122 [GO] 2021―Dec―23 A Bivalent Nanoparticle Vaccine Exhibits Potent Cross-protection against the Variants of SARS-CoV-2 Yaochang Yuan, Xiantao Zhang, Ran Chen, Yuzhuang Li, Bolin Wu, Rong Li, et al. (+19)
123 [GO] 2021―Dec―22 SARS-CoV-2 reactive and neutralizing antibodies discovered by single cell sequencing of plasma cells and mammalian display Roy A. Ehling, Cédric R. Weber, Derek M. Mason, Simon Friedensohn, Bastian Wagner, Florian Bieberich, et al. (+14)
124 [GO] 2021―Dec―21 Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naïve and subjects recovered from COVID-19 Roberto Lozano-Rodríguez, Jaime Valentín-Quiroga, José Avendaño-Ortiz, Alejandro Martín-Quirós, Alejandro Pascual-Iglesias, Verónica Terrón, et al. (+21)
125 [GO] 2021―Dec―21 High Titer Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies of Previously Infected Individuals Takuya Tada, Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Amber Cornelius, Ramin S. Herati, et al. (+2)
126 [GO] 2021―Dec―21 Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies Claudia A. Jette, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Frauke Muecksch, Yu E. Lee, Kathryn E. Huey-Tubman, et al. (+8)
127 [GO] 2021―Dec―18 The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance Izumi Kimura, Yusuke Kosugi, Jiaqi Wu, Jiri Zahradnik, Daichi Yamasoba, Erika P. Butlertanaka, et al. (+17)
128 [GO] 2021―Dec―17 Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection Karolin I. Wagner, Laura M. Mateyka, Sebastian Jarosch, Vincent Grass, Simone Weber, Kilian Schober, et al. (+26)
129 [GO] 2021―Dec―16 Two-step fitness selection for intra-host variations in SARS-CoV-2 Jiarui Li, Pengcheng Du, Lijiang Yang, Ju Zhang, Chuan Song, Danying Chen, et al. (+27)
130 [GO] 2021―Dec―15 Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern Wenwei Li, Yaozong Chen, Jérémie Prévost, Irfan Ullah, Maolin Lu, Shang Yu Gong, et al. (+24)
131 [GO] 2021―Dec―10 HLA-A∗02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses Pavlo A. Nesterenko, Jami McLaughlin, Brandon L. Tsai, Giselle Burton Sojo, Donghui Cheng, Daniel Zhao, et al. (+17)
132 [GO] 2021―Dec―08 SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity M. Gordon Joyce, Wei-Hung Chen, Rajeshwer S. Sankhala, Agnes Hajduczki, Paul V. Thomas, Misook Choe, et al. (+54)
133 [GO] 2021―Dec―07 Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses Paul R. Wratil, Niklas A. Schmacke, Burak Karakoc, Alex Dulovic, Daniel Junker, Matthias Becker, et al. (+20)
134 [GO] 2021―Dec―04 Structural Analysis of Receptor Binding Domain Mutations in SARS-CoV-2 Variants of Concern that Modulate ACE2 and Antibody Binding Dhiraj Mannar, James W. Saville, Xing Zhu, Shanti S. Srivastava, Alison M. Berezuk, Steven Zhou, et al. (+5)
135 [GO] 2021―Dec―03 IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virus Yang Yu, Na Xu, Qi Cheng, Fei Deng, Meiqin Liu, Airu Zhu, et al. (+21)
136 [GO] 2021―Nov―24 Anti-SARS-CoV-2 antibodies elicited by COVID-19mRNA vaccine exhibit a unique glycosylation pattern Inbal Farkash, Tali Feferman, Noy Cohen-Saban, Yahel Avraham, David Morgenstern, Grace Mayuni, et al. (+8)
137 [GO] 2021―Nov―24 Two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge Wenwen Jiang, Li Shi, Lukui Cai, Xiaoyu Wang, Jingyan Li, Heng Li, et al. (+6)
138 [GO] 2021―Nov―10 Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation Woan-Ing Twu, Ji-Young Lee, Heeyoung Kim, Vibhu Prasad, Berati Cerikan, Uta Haselmann, et al. (+2)
139 [GO] 2021―Nov―03 SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a wide variety of tissues Matteo D’Antonio, Jennifer P. Nguyen, Timothy D. Arthur, Hiroko Matsui, Agnieszka D’Antonio-Chronowska, Kelly A. Frazer
140 [GO] 2021―Oct―22 Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection Krista M. Pullen, Caroline Atyeo, Ai-Ris Y. Collier, Kathryn J. Gray, Mandy B. Belfort, Douglas A. Lauffenburger, et al. (+2)
141 [GO] 2021―Oct―22 Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome Weifan Xu, Gaofeng Pei, Hongrui Liu, Xiaohui Ju, Jing Wang, Qiang Ding, Pilong Li
142 [GO] 2021―Oct―20 Monoclonal antibodies protect aged rhesus macaques from SARS-CoV-2-induced immune activation and neuroinflammation Anil Verma, Chase E. Hawes, Yashavanth Shaan Lakshmanappa, Jamin W. Roh, Brian A. Schmidt, Joseph Dutra, et al. (+17)
143 [GO] 2021―Oct―19 Stabilized Coronavirus Spike Stem Elicits a Broadly Protective Antibody Ching-Lin Hsieh, Anne P. Werner, Sarah R. Leist, Laura J. Stevens, Ester Falconer, Jory A. Goldsmith, et al. (+14)
144 [GO] 2021―Oct―19 Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain Gabriele Cerutti, Yicheng Guo, Pengfei Wang, Manoj S. Nair, Maple Wang, Yaoxing Huang, et al. (+9)
145 [GO] 2021―Oct―16 An Airway Organoid-Based Screen Identifies a Role for the HIF1α-Glycolysis Axis in SARS-CoV-2 Infection Xiaohua Duan, Xuming Tang, Manoj S. Nair, Tuo Zhang, Yunping Qiu, Wei Zhang, et al. (+8)
146 [GO] 2021―Oct―12 Mechanistic Insights into COVID-19 by Global Analysis of the SARS-CoV-2 3CLpro Substrate Degradome Isabel Pablos, Yoan Machado, Hugo C. Ramos de Jesus, Yasir Mohamud, Reinhild Kappelhoff, Cecilia Lindskog, et al. (+20)
147 [GO] 2021―Oct―09 Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD John M. Errico, Haiyan Zhao, Rita E. Chen, Zhuoming Liu, James Brett Case, Meisheng Ma, et al. (+8)
148 [GO] 2021―Oct―09 Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex Jiqin Wu, Haofeng Wang, Qiaojie Liu, Rui Li, Yan Gao, Xiang Fang, et al. (+5)
149 [GO] 2021―Oct―08 A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration Xilin Wu, Lin Cheng, Ming Fu, Bilian Huang, Linjing Zhu, Shijie Xu, et al. (+8)
150 [GO] 2021―Oct―06 In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential Brandon Lam, Yu Jui Kung, John Lin, Ssu-Hsueh Tseng, Ya Chea Tsai, Liangmei He, et al. (+9)
151 [GO] 2021―Sep―30 Role of miR-2392 in Driving SARS-CoV-2 Infection J. Tyson McDonald, Francisco Javier Enguita, Deanne Taylor, Robert J. Griffin, Waldemar Priebe, Mark R. Emmett, et al. (+42)
152 [GO] 2021―Sep―30 The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression Aaron S. Mendez, Michael Ly, Angélica M. González-Sánchez, Ella Hartenian, Nicholas T. Ingolia, Jamie H. Cate, Britt A. Glaunsinger
153 [GO] 2021―Sep―28 Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses Bailey B. Banach, Gabriele Cerutti, Ahmed S. Fahad, Chen-Hsiang Shen, Matheus Oliveira De Souza, Phinikoula S. Katsamba, et al. (+28)
154 [GO] 2021―Sep―27 High affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines Kathryn A. Pape, Thamotharampillai Dileepan, Amanda J. Kabage, Daria Kozysa, Rodolfo Batres, Clayton Evert, et al. (+10)
155 [GO] 2021―Sep―27 Landscape of human antibody recognition of the SARS-CoV-2 Receptor Binding Domain Adam K. Wheatley, Phillip Pymm, Robyn Esterbauer, Melanie H. Dietrich, Wen Shi Lee, Damien Drew, et al. (+27)
156 [GO] 2021―Sep―21 A highly potent antibody effective against SARS-CoV-2 variants of concern Craig Fenwick, Priscilla Turelli, Laurent Perez, Céline Pellaton, Line Esteves-Leuenberger, Alex Farina, et al. (+24)
157 [GO] 2021―Sep―20 Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19 Dong-Min Kim, Yuri Kim, Jun-Won Seo, Jooyeon Lee, Uni Park, Na-Young Ha, et al. (+31)
158 [GO] 2021―Sep―17 Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes Nianping Liu, Chen Jiang, Pengfei Cai, Zhuoqiao Shen, Wujianan Sun, Hao Xu, et al. (+8)
159 [GO] 2021―Sep―16 Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition Kevin J. Kramer, Nicole V. Johnson, Andrea R. Shiakolas, Naveenchandra Suryadevara, Sivakumar Periasamy, Nagarajan Raju, et al. (+16)
160 [GO] 2021―Sep―15 Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity Maria Vono, Angela Huttner, Sylvain Lemeille, Paola Martinez-Murillo, Benjamin Meyer, Stephanie Baggio, et al. (+14)
161 [GO] 2021―Sep―08 Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies Claudia A. Jette, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Frauke Muecksch, Yu E. Lee, Kathryn E. Huey-Tubman, et al. (+8)
162 [GO] 2021―Sep―08 A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease Stephanie Patchett, Zongyang Lv, Wioletta Rut, Miklos Bekes, Marcin Drag, Shaun K. Olsen, Tony T. Huang
163 [GO] 2021―Aug―27 Profiling CD8+ T Cell Epitopes of COVID-19 Convalescents Reveals Reduced Cellular Immune Responses to SARS-CoV-2 Variants Hang Zhang, Shasha Deng, Liting Ren, Peiyi Zheng, Xiaowen Hu, Tengchuan Jin, Xu Tan
164 [GO] 2021―Aug―17 Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2 Tanushree Dangi, Jacob Class, Nicole Palacio, Justin M. Richner, Pablo Penaloza-MacMaster
165 [GO] 2021―Aug―17 The nucleotide addition cycle of the SARS-CoV-2 polymerase Subhas Chandra Bera, Mona Seifert, Robert N. Kirchdoerfer, Pauline van Nies, Yibulayin Wubulikasimu, Salina Quack, et al. (+6)
166 [GO] 2021―Aug―13 Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose Nicholas S. Rhoades, Amanda N. Pinski, Alisha N. Monsibais, Allen Jankeel, Brianna M. Doratt, Isaac R. Cinco, et al. (+2)
167 [GO] 2021―Aug―10 One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening Irene M. Francino-Urdaniz, Paul J. Steiner, Monica B. Kirby, Fangzhu Zhao, Cyrus M. Haas, Shawn Barman, et al. (+6)
168 [GO] 2021―Aug―10 Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals Elaine C. Chen, Pavlo Gilchuk, Seth J. Zost, Naveenchandra Suryadevara, Emma S. Winkler, Carly R. Cabel, et al. (+16)
169 [GO] 2021―Aug―06 Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms Michael J. Peluso, Amelia N. Deitchman, Leonel Torres, Nikita S. Iyer, Sadie E. Munter, Christopher C. Nixon, et al. (+23)
170 [GO] 2021―Aug―04 Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals Daniel Lozano-Ojalvo, Carmen Camara, Eduardo Lopez-Granados, Pilar Nozal, Lucía del Pino-Molina, Yadira Bravo-Gallego, et al. (+26)
171 [GO] 2021―Jul―28 No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing Nathan Smits, Jay Rasmussen, Gabriela O. Bodea, Alberto A. Amarilla, Patricia Gerdes, Francisco J. Sanchez-Luque, et al. (+9)
172 [GO] 2021―Jul―23 Systemic IL-15, IFN-γ and IP-10/CXCL10 Signature Associated with Effective Immune Response to SARS-CoV-2 in BNT162b2 mRNA Vaccine Recipients Cristina Bergamaschi, Evangelos Terpos, Margherita Rosati, Matthew Angel, Jenifer Bear, Dimitris Stellas, et al. (+9)
173 [GO] 2021―Jul―20 Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication Caroline G. Williams, Alexander S. Jureka, Jesus A. Silvas, Anthony M. Nicolini, Stacie A. Chvatal, Jared Carlson-Stevermer, et al. (+3)
174 [GO] 2021―Jul―20 Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding Jakob Trimpert, Kristina Dietert, Theresa C. Firsching, Nadine Ebert, Tran Thi Nhu Thao, Daria Vladimirova, et al. (+12)
175 [GO] 2021―Jul―17 Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome Weifan Xu, Gaofeng Pei, Hongrui Liu, Xiaohui Ju, Jing Wang, Qiang Ding, Pilong Li
176 [GO] 2021―Jul―10 Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice David R. Martinez, Alexandra Scha¨fer, Sarah R. Leist, Dapeng Li, Kendra Gully, Boyd Yount, et al. (+9)
177 [GO] 2021―Jul―10 An intranasal vaccine durably protects against SARS-CoV-2 variants in mice Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, Baoling Ying, Dansu Yaun, Saravanan Raju, et al. (+13)
178 [GO] 2021―Jul―07 A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations Federico Bertoglio, Viola Fühner, Maximilian Ruschig, Philip Alexander Heine, Leila Abassi, Thomas Klünemann, et al. (+35)
179 [GO] 2021―Jul―07 Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy Rafet Basar, Nadima Uprety, Emily Ensley, May Daher, Kimberly Klein, Fernando Martinez, et al. (+28)
180 [GO] 2021―Jun―29 Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19 Jason Neidleman, Xiaoyu Luo, Ashley F. George, Matthew McGregor, Junkai Yang, Cassandra Yun, et al. (+8)
181 [GO] 2021―Jun―29 A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters Traci L. Bricker, Tamarand L. Darling, Ahmed O. Hassan, Houda H. Harastani, Allison Soung, Xiaoping Jiang, et al. (+10)
182 [GO] 2021―Jun―29 SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, Amy Kempf, Inga Nehlmeier, Luise Graichen, et al. (+9)
183 [GO] 2021―Jun―26 Antibody landscape against SARS-CoV-2 proteome reveals significant differences between non-structural/ accessory proteins and structural proteins Yang Li, Zhaowei Xu, Qing Lei, Dan-yun Lai, Hongyan Hou, He-wei Jiang, et al. (+19)
184 [GO] 2021―Jun―25 Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19 Yu Kaku, Takeo Kuwata, Hasan Md Zahid, Takao Hashiguchi, Takeshi Noda, Noriko Kuramoto, et al. (+23)
185 [GO] 2021―Jun―23 Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell Maritza Puray-Chavez, Kyle M. LaPak, Travis P. Schrank, Jennifer L. Elliott, Dhaval P. Bhatt, Megan J. Agajanian, et al. (+25)
186 [GO] 2021―Jun―22 Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects Madeleine F. Jennewein, Anna J. MacCamy, Nicholas R. Akins, Junli Feng, Leah J. Homad, Nicholas K. Hurlburt, et al. (+23)
187 [GO] 2021―Jun―11 Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help Jernej Pušnik, Enrico Richter, Bianca Schulte, Ramona Dolscheid-Pommerich, Christian Bode, Christian Putensen, et al. (+3)
188 [GO] 2021―Jun―08 Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA-peptidomics Adi Nagler, Shelly Kalaora, Chaya Barbolin, Anastasia Gangaev, Steven L.C. Ketelaars, Michal Alon, et al. (+13)
189 [GO] 2021―Jun―08 Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the variant of concern lineage B.1.1.7 Bo Meng, Steven A. Kemp, Guido Papa, Rawlings Datir, Isabella ATM. Ferreira, Sara Marelli, et al. (+22)
190 [GO] 2021―May―19 Direct Derivation of Human Alveolospheres for SARS-CoV-2 Infection Modeling and Drug Screening Toshiki Ebisudani, Shinya Sugimoto, Kei Haga, Akifumi Mitsuishi, Reiko Takai-Todaka, Masayuki Fujii, et al. (+9)
191 [GO] 2021―May―14 SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression. Artem Nemudryi, Anna Nemudraia, Tanner Wiegand, Joseph Nichols, Deann T. Snyder, Jodi F. Hedges, et al. (+6)
192 [GO] 2021―May―13 Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells Robert Parker, Thomas Partridge, Catherine Wormald, Rebeca Kawahara, Victoria Stalls, Maria Aggelakopoulou, et al. (+10)
193 [GO] 2021―May―09 Dynamics of B-cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19 Zachary Montague, Huibin Lv, Jakub Otwinowski, William S. DeWitt, Giulio Isacchini, Garrick K. Yip, et al. (+9)
194 [GO] 2021―May―03 METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection Na Li, Hui Hui, Bill Bray, Gwendolyn Michelle Gonzalez, Mark Zeller, Kristian G. Anderson, et al. (+5)
195 [GO] 2021―Apr―27 Hepatitis C Virus Drugs That Inhibit the SARS-CoV-2 Papain-Like Protease Synergize with Remdesivir to Suppress Viral Replication in Cell Culture Khushboo Bafna, Kris White, Balasubramanian Harish, Romel Rosales, Theresa A. Ramelot, Thomas B. Acton, et al. (+7)
196 [GO] 2021―Apr―27 Systematic Functional Analysis of SARS-CoV-2 Proteins Uncovers Viral Innate Immune Antagonists and Remaining Vulnerabilities Manuel Hayn, Maximilian Hirschenberger, Lennart Koepke, Rayhane Nchioua, Jan Hendrik Straub, Susanne Klute, et al. (+18)
197 [GO] 2021―Apr―24 Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2 Xiaojuan Zhou, Fengge Ma, Jun Xie, Meng Yuan, Yunqiao Li, Namir Shaabani, et al. (+18)
198 [GO] 2021―Apr―23 Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection Jessie J.-Y. Chang, Daniel Rawlinson, Miranda E. Pitt, George Taiaroa, Josie Gleeson, Chenxi Zhou, et al. (+10)
199 [GO] 2021―Apr―15 SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery Apoorva Mulay, Bindu Konda, Gustavo Garcia, Changfu Yao, Stephen Beil, Jaquelyn Mary Villalba, et al. (+12)
200 [GO] 2021―Apr―05 Hypoxic and pharmacological activation of HIFs inhibits SARS-CoV-2 infection of lung epithelial cells Peter AC. Wing, Thomas P. Keeley, Xiaodong Zhuang, Jeffrey Y. Lee, Maria Prange-Barczynska, Senko Tsukuda, et al. (+17)
201 [GO] 2021―Apr―03 SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization Markus Hoffmann, Lu Zhang, Nadine Krüger, Luise Graichen, Hannah Kleine-Weber, Heike Hofmann-Winkler, et al. (+7)
202 [GO] 2021―Apr―02 Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction Shiho Torii, Chikako Ono, Rigel Suzuki, Yuhei Morioka, Itsuki Anzai, Yuzy Fauzyah, et al. (+4)
203 [GO] 2021―Mar―31 Cell-type-specific immune dysregulation in severely ill COVID-19 patients Changfu Yao, Stephanie A. Bora, Tanyalak Parimon, Tanzira Zaman, Oren A. Friedman, Joseph A. Palatinus, et al. (+15)
204 [GO] 2021―Mar―23 Drug repurposing screens reveal cell-type specific entry pathways and FDA approved drugs active against SARS-Cov-2 Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Elisha Segrist, Minghua Li, Brinda Kamalia, et al. (+9)
205 [GO] 2021―Mar―20 Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class Micah Rapp, Yicheng Guo, Eswar R. Reddem, Jian Yu, Lihong Liu, Pengfei Wang, et al. (+11)
206 [GO] 2021―Mar―19 Antiviral Drug Screen Identifies DNA-Damage Response Inhibitor as Potent Blocker of SARS-CoV-2 Replication Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah, Chandani Sen, Arunima Purkayastha, Donald B. Kohn, et al. (+22)
207 [GO] 2021―Mar―18 Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies Nicola Cotugno, Alessandra Ruggiero, Francesco Bonfante, Maria Raffaella Petrara, Sonia Zicari, Giuseppe Rubens Pascucci, et al. (+39)
208 [GO] 2021―Mar―14 Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients Yang Li, Ming-liang Ma, Qing Lei, Feng Wang, Wei Hong, Dan-yun Lai, et al. (+22)
209 [GO] 2021―Mar―07 The impact of Spike mutations on SARS-CoV-2 neutralization Chloe Rees-Spear, Luke Muir, Sarah A. Griffith, Judith Heaney, Yoann Aldon, Jonne L. Snitselaar, et al. (+15)
210 [GO] 2021―Feb―26 Metabolic programs define dysfunctional immune responses in severe COVID-19 patients Elizabeth A. Thompson, Katherine Cascino, Alvaro A. Ordonez, Weiqiang Zhou, Ajay Vaghasia, Anne Hamacher-Brady, et al. (+20)
211 [GO] 2021―Feb―23 Use of convalescent serum reduces severity of COVID-19 in nonhuman primates Robert W. Cross, Abhishek N. Prasad, Viktoriya Borisevich, Courtney Woolsey, Krystle N. Agans, Daniel J. Deer, et al. (+4)
212 [GO] 2021―Feb―10 Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 Romain Gasser, Marc Cloutier, Jérémie Prévost, Corby Fink, Éric Ducas, Shilei Ding, et al. (+14)
213 [GO] 2021―Feb―05 SARS-CoV-2 ORF9b Inhibits RIG-I-MAVS Antiviral Signaling by Interrupting K63-Linked Ubiquitination of NEMO Jing Wu, Yuheng Shi, Xiaoyan Pan, Shuang Wu, Ruixia Hou, Yong Zhang, et al. (+11)
214 [GO] 2021―Jan―26 Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 Timothy A. Bates, Jules B. Weinstein, Scotland Farley, Hans C. Leier, William B. Messer, Fikadu G. Tafesse
215 [GO] 2021―Jan―26 The immunodominant and neutralization linear epitopes for SARS-CoV-2 Shuai Lu, Xi-xiu Xie, Lei Zhao, Bin Wang, Jie Zhu, Ting-rui Yang, et al. (+17)
216 [GO] 2021―Jan―22 Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients Anthony T. Tan, Martin Linster, Chee Wah Tan, Nina Le Bert, Wan Ni Chia, Kamini Kunasegaran, et al. (+10)
217 [GO] 2021―Jan―14 MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells Xin Yin, Laura Riva, Yuan Pu, Laura Martin-Sancho, Jun Kanamune, Yuki Yamamoto, et al. (+10)
218 [GO] 2021―Jan―14 Enhancement versus Neutralization by SARS-CoV-2 Antibodies from A Convalescent Donor Associates with Distinct Epitopes on the Receptor-Binding Domain Yunjiao Zhou, Zezhong Liu, Shibo Li, Wei Xu, Qianqian Zhang, Israel T. Silva, et al. (+19)
219 [GO] 2020―Dec―26 D614G mutation alters SARS-CoV-2 spike conformation and enhances protease cleavage at the S1/S2 junction Sophie M-C. Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Kartik Manne, et al. (+6)
220 [GO] 2020―Dec―17 Cell type-specific immune dysregulation in severely ill COVID-19 patients Changfu Yao, Stephanie A. Bora, Tanyalak Parimon, Tanzira Zaman, Oren A. Friedman, Joseph A. Palatinus, et al. (+15)
221 [GO] 2020―Dec―01 A soluble ACE2 microbody protein fused to a single immunoglobulin Fc domain is a potent inhibitor of SARS-CoV-2 Takuya Tada, Chen Fan, Jennifer S. Chen, Ramanjit Kaur, Kenneth A. Stapleford, Harry Gristick, et al. (+4)
222 [GO] 2020―Nov―19 The Roborovski dwarf hamster - a highly susceptible model for a rapid and fatal course of SARS-CoV-2 infection Jakob Trimpert, Daria Vladimirova, Kristina Dietert, Azza Abdelgawad, Dusan Kunec, Simon Dökel, et al. (+4)
223 [GO] 2020―Nov―13 The Human Leukocyte Antigen Class II Immunopeptidome of SARS-CoV-2 Spike Glycoprotein Michael D. Knierman, Megan B. Lannan, Laura J. Spindler, Carl L. McMillian, Robert J. Konrad, Robert W. Siegel
224 [GO] 2020―Nov―03 HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon Jonathan J. Miner, Derek J. Platt, Cyrus M. Ghaznavi, Pallavi Chandra, Andrea Santeford, Amber M. Menos, et al. (+6)
225 [GO] 2020―Oct―20 High-density amplicon sequencing identifies community spread and ongoing evolution of SARS-CoV-2 in the Southern United States Ryan P. McNamara, Carolina Caro-Vegas, Justin T. Landis, Razia Moorad, Linda J. Pluta, Anthony B. Eason, et al. (+19)
226 [GO] 2020―Oct―12 Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes Tongqing Zhou, I-Ting Teng, Adam S. Olia, Gabriele Cerutti, Jason Gorman, Alexandra Nazzari, et al. (+32)
227 [GO] 2020―Sep―29 An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain Nicholas C. Wu, Meng Yuan, Hejun Liu, Chang-Chun D. Lee, Xueyong Zhu, Sandhya Bangaru, et al. (+7)
228 [GO] 2020―Sep―23 Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects Ya-Wen Cheng, Tai-Ling Chao, Chiao-Ling Li, Mu-Fan Chiu, Han-Chieh Kao, Sheng-Han Wang, et al. (+11)
229 [GO] 2020―Sep―19 Evasion of type-I interferon by SARS-CoV-2 Hongjie Xia, Zengguo Cao, Xuping Xie, Xianwen Zhang, John Yun-Chung Chen, Hualei Wang, et al. (+3)
230 [GO] 2020―Sep―06 Activation of the SARS-CoV-2 receptor Ace2 through JAK/STAT-dependent enhancers during pregnancy Lothar Hennighausen, Hye Kyung Lee
231 [GO] 2020―Sep―04 SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant Yoriyuki Konno, Izumi Kimura, Keiya Uriu, Masaya Fukushi, Takashi Irie, Yoshio Koyanagi, et al. (+4)
232 [GO] 2020―Sep―03 A single-cell RNA expression map of human coronavirus entry factors Manvendra Singh, Vikas Bansal, Cédric Feschotte
233 [GO] 2020―Jul―24 A carbohydrate-binding protein from the edible Lablab beans effectively blocks the infections of influenza viruses and SARS-CoV-2 Yo-Min Liu, Md. Shahed-Al-Mahmud, Xiaorui Chen, Ting-Hua Chen, Kuo-Shiang Liao, Jennifer M. Lo, et al. (+6)
234 [GO] 2020―Jul―07 Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer, Sarah R. Leist, Lisa E. Gralinksi, Kenneth H. Dinnon, et al. (+23)
235 [GO] 2020―Jul―03 Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection François Trottein, Harry Sokol
236 [GO] 2020―Jul―03 Human IgG neutralizing monoclonal antibodies block SARS-CoV-2 infection Jinkai Wan, Shenghui Xing, Longfei Ding, Yongheng Wang, Chenjian Gu, Yanling Wu, et al. (+20)
237 [GO] 2020―May―30 Structural and biochemical characterization of nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2 Qi Peng, Ruchao Peng, Bin Yuan, Jingru Zhao, Min Wang, Xixi Wang, et al. (+6)
238 [GO] 2020―May―18 Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections Huibin Lv, Nicholas C. Wu, Owen Tak-Yin Tsang, Meng Yuan, Ranawaka A.P. M. Perera, Wai Shing Leung, et al. (+13)
239 [GO] 2020―May―08 Publishing in a Pandemic: The View from Cell Reports The Cell Reports Editorial Team
 [1] 

239 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.019 sec